Over the past few years, a new class of medications has transformed the treatment of obesity. Drugs like Ozempic, Wegovy and Mounjaro work primarily by reducing appetite, helping people eat less and ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

A recent small study has found that people may be able to maintain their weight loss with fewer GLP-1 injections, but this ...

A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce broadly consistent weight-loss results across age, race, ethnicity, and ...

This article was reviewed by Lynn Marie Morski, MD, JD. There’s not much research on B12 shots for weight loss. People with obesity tend to have lower vitamin B12 levels, but it’s unclear if B12 shots ...

In this week’s STATus Report, host Alex Hogan explains why weight loss pills were so much harder to develop than injectables.

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the ...

A large study found that people taking GLP-1 drugs like Ozempic for diabetes were less likely to be diagnosed with substance use disorder.

Gypsy-Rose Blanchard is responding to rumors that she's used a GLP-1 to lose weight.

Of all the baseless fitness myths to have been peddled through ages of infomercials and influencers alike, the notion that you can “blast belly fat” is among the most audacious. Targeted fat loss, or ...